Australis Capital Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AUSAF research report →
Price Chart
About the company
Australis Capital Inc. functions as a cannabis enterprise, actively pursuing both cannabis and horticultural ventures. These projects span a broad international landscape, encompassing the United States, Canada, Denmark, Finland, Iceland, Germany, the Netherlands, Bahrain, the United Arab Emirates, Southeast Asia, Australia, and numerous other global territories.
- CEO
- Terrance R. Booth
- IPO
- 2018
- Employees
- 18
- HQ
- Las Vegas, NV, US
Get TickerSpark's AI analysis on AUSAF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.78K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.13
- Div Yield
- 0.00%
- Gross Margin
- 52.39%
- Op Margin
- -255.97%
- Net Margin
- -661.50%
- ROE
- -143.69%
- ROIC
- -36.79%
Latest fiscal year · YoY change
- Revenue
- $7.57M+955.8%
- Gross Profit
- $3.97M+2054.2%
- Op Income
- $-19,382,000
- Net Income
- $-50,088,992-98.3%
- EPS
- $-0.16-14.3%
- OCF Growth
- -50.3%
- FCF Growth
- -30.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.34
- RSI (14)
- 49
- Avg Volume
- 44.08K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Australis said Q3 was a transitional quarter, with revenue up sharply year over year, gross profit turning positive, and management leaning into cannabis operating assets in California, Nevada, New York, Thailand, and ALPS projects.· March 2, 2022
- Revenue increased more than 2,400% year over year and was up 4.4% sequentially to $2.4 million.
- Gross profit improved to $1.8 million from a $0.2 million loss a year ago, helped by higher ALPS utilization and better margins.
- Management said California product launches sold out quickly, leading to a larger second production run.
- The company highlighted early-mover opportunities in New York, Thailand, Missouri, and Florida, while continuing to pursue licenses and acquisitions.
- Management said Body and Mind holdings are being wound down, with $2.9 million remaining on the balance sheet at the end of December.
Q3 revenue was $2.4 million, up more than 2,400% year over year and up 4.4% sequentially. Gross profit was $1.8 million versus a $0.2 million gross loss in the prior-year quarter, and gross profit improved 49% versus Q2. Operating expenses were 26% higher year over year and 9% higher than Q2, while operating costs were said to be 14.7% lower than last year and 2% lower than Q2. Trailing 12-month pro forma revenue was $9.9 million, up 14% from the prior quarter’s trailing 12-month figure. Management did not provide formal next-quarter or full-year financial guidance, but said it expects strong growth as GT results are consolidated, ALPS projects advance, and California, Nevada, Thailand, and New York initiatives scale.
Terry Booth framed the quarter as proof that Australis is transitioning from an investment company into an operating cannabis business, with growth coming from ALPS, California, New York, Thailand, and other markets. His tone was very optimistic and expansion-focused, emphasizing first-mover advantages, social equity positioning, and a broad pipeline of projects. He repeatedly pointed to upcoming launches, license applications, and international partnerships as the basis for future growth.
Jon Paul emphasized that Q3 was a “pivotal transitional quarter” where the company spent heavily on future revenue opportunities while still growing revenue. He cited $2.4 million of sales, $1.8 million of gross profit, $9.9 million of trailing 12-month pro forma revenue, and a 49% sequential improvement in gross profit driven by ALPS utilization and margins. He also outlined year-to-date capital deployment: $1.7 million for APIS development, $2.4 million advanced for a cultivation buildout, $1.9 million for Sandy Valley land and water rights, plus a $3 million equity raise, $4.1 million from land sales, and a $3.5 million reduction in Body and Mind investment.
Analysts focused on Thailand, New York, Missouri/Oklahoma, Florida, and the remaining Body and Mind stake. Management said New York offers a first-mover edge because draft regulations are expected in April or early May, indigenous lands may operate outside state rules, and the company is positioning for social equity and hemp entry points. On Missouri, management said a 1,000-square-foot manufacturing facility is operating but is not yet highly profitable, while Oklahoma is lower priority; on Florida, they said licenses are expensive and may be pursued through applications, milestones, or acquisition structures. The company said $2.9 million of Body and Mind shares remained at quarter-end and expects to exit the position by fiscal Q4.
The bullish case from this call is that the company is showing real operating traction, not just strategy: revenue is up sharply, gross profit is positive, and California products sold out quickly. Management also believes it has early positioning in several potentially large markets, especially New York and Thailand, plus a growing ALPS pipeline that could support more revenue and margin expansion.
The main risks are execution and financing: management is still spending heavily on projects, many initiatives are early-stage, and several markets depend on licensing, regulation, or future legalization. The call also showed the business is still partially reliant on non-core moves and asset monetization, with Body and Mind being wound down and Florida licenses described as very expensive.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 95.6%
- Shares Outstanding
- 278.28M
- Float Shares
- 266.05M
Our AUSAF coverage
Recent articles, reports, and earnings notes.
No research on AUSAF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AUSAF report →CSE Bulletin: Delist - Australis Capital Inc. (AUSA)
newsfilecorp.com · May 12
Australis Capital Inc. Corporate Update March 15, 2024
headlinesoftoday.com · Mar 16
Australis Capital doing business as Audacious announces management changes
proactiveinvestors.com · Dec 19
Australis Capital says conditional licenses can be converted to annual adult usage cultivation and manufacturing licenses in New Jersey
proactiveinvestors.com · Oct 28
Australis Capital announces start of cannabis cultivation in Broome County, New York
proactiveinvestors.com · Sep 23
Audacious expands footprint in New York State with new cultivation assets for the adult use cannabis market
proactiveinvestors.com · Jun 23
Australis Capital commences construction of New York cultivation, manufacturing and retail project
proactiveinvestors.com · May 26
AUDACIOUS' Booth to Present at Lift & Co Conference
prnewswire.com · May 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.